CC
ALT icon

Corton Capital’s Altimmune ALT Stock Holding History

Corton Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,202
Closed -$26.5K – 567
2023
Q3 		$26.5K Sell
10,202
-30,911
-75% -$88.7K 0.01% 413
2023
Q2 		$145K Buy
+41,113
New +$185K 0.07% 370
2022
Q3 		– Sell
-17,875
Closed -$209K – 271
2022
Q2 		$209K Buy
+17,875
New +$110K 0.2% 226

Other funds holding ALT

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Corton Capital's ALT Position: Q4 2023 in Review

Corton Capital sold out of Altimmune (ALT) in Q4 2023, closing a stake of 10,202 shares — an estimated $26.5K sold.

Corton Capital first reported a position in ALT in Q2 2022 and held it in 3 quarters. The position peaked at $209K in Q2 2022. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

  • Corton Capital reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
  • Corton Capital sold 10,202 Altimmune shares in Q4 2023, an estimated $26.5K.
  • Corton Capital first reported a position in Altimmune in Q2 2022 and held it in 3 quarters.
  • Corton Capital's Altimmune position peaked at $209K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Corton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.